<DOC>
	<DOCNO>NCT02213575</DOCNO>
	<brief_summary>This study mechanistic study enroll 9 subject participate NCT02133885 ( design evaluate minocycline test hypothesis minocycline treatment would produce antihypertensive effect drug-resistant neurogenic hypertensive individual ) test whether antihypertensive effect minocycline associate decrease activate microglia central nervous system autonomic region evidence change PET MRI imaging .</brief_summary>
	<brief_title>Study 3 : Minocycline Decreases Microglia Activation</brief_title>
	<detailed_description>This study recruit 9 subject NCT02133885 agree undergo additional autonomic test image study baseline 3-6 month study treatment . Specialized image brain use magnetic resonance imaging ( MRI ) positron emission tomography ( PET ) scan conduct Montreal Neurological Institute , Montreal Canada .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Subjects participate IRB approve protocol # 1022013 eligible participate . Exclusion criterion control resistant hypertensive subject include : currently pregnant pregnant last 6 month ; antibiotic treatment within 2 month study enrollment ; currently take medication ( e.g. , antibiotic , antiinflammatory agent , glucocorticoid immune modulate medication ) ; unwilling discontinue vitamin supplement , include probiotic , potentially affect gut microbiota ( vitamins/supplements medication possibly affect gut microbiota discontinue least 2wks prior stool collection ) ; history intestinal surgery , inflammatory bowel disease , celiac disease , lactose intolerance , chronic pancreatitis malabsorption disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Resistent Hypertension</keyword>
</DOC>